Back to search
FDAFDA · Food and drugs·Recall number D-0165-2025

Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA

Published January 1, 2025 · Recall initiated: December 2, 2024

Summary

FDA records drug Class II recall D-0165-2025, published January 1, 2025 and initiated December 2, 2024. Recalling firm: RemedyRepack Inc.; Status: Ongoing; Reported quantity: a) 1,564 cards, b) 799 bottles; Lot: a) NDC 70518-0937-04, Lot # J0786744-061724, Exp. 06/30/2025 b) NDC 70518-0937-03, Lot # B3002625-060524, Exp. 10/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
Nationwide in the US
Lot
a) NDC 70518-0937-04, Lot # J0786744-061724, Exp. 06/30/2025 b) NDC 70518-0937-03, Lot # B3002625-060524, Exp. 10/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA recalled?

Yes. FDA published recall D-0165-2025 on January 1, 2025. Reported hazard: CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.

What should I do if I have this product?

Voluntary: Firm initiated · Letter